Papers by Gregory G. Schwartz · AgingResearch.News

American Heart Journal8 Aug
HPS-4/TIMI 65/ORION-4: A double-blind randomized placebo-controlled trial assessing the effects of inclisiran on clinical outcomes among people with atherosclerotic cardiovascular disease: Trial design, recruitment, and baseline characteristics
Trial in peopleInterventions
Paper
AHA Scientific Sessions 2025 Abstract3 Nov
Small, Dense LDL-C and Conventional LDL-C Similarly Predict Cardiovascular Risk and Benefit of Alirocumab in Statin-Treated Patients With Recent Acute Coronary Syndrome
Trial in peopleBiomarkers
Paper